TCG Crossover GP I, LLC 13D and 13G filings for CG Oncology, Inc. Common stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:32 pm Purchase |
2025-03-31 | 13G | CG Oncology, Inc. Common stock CGON |
TCG Crossover GP I, LLC | 3,670,206 4.800% |
100,000 (+2.80%) |
Filing |
| 2024-02-09 4:31 pm Purchase |
2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON |
TCG Crossover GP I, LLC | 3,570,206 5.400% |
3,570,206 (New Position) |
Filing |